Vineet Jindal | VP, Corporate Communications & Strategy |
Warren Huff | President and Chief Executive Officer |
Colin Meyer | Chief Research and Development Officer and EVP |
Manmeet Soni | Chief Operating Officer, Chief Financial Officer and EVP |
Yigal Nochomovitz | Citigroup |
Maurice Raycroft | Jefferies |
Joseph Schwartz | SVB Leerink |
Annabel Samimy | Stifel |
Brian Skorney | Baird |
Dae Gon Ha | BTIG |
Hello and welcome to the Reata Pharmaceuticals Second Quarter Financial Results and Update Development Programs Call. My name is Sheryl and I will be your operator for today's call. [Operator Instructions] Please note that this conference call is being recorded.
Before we begin, I'd like to go over a few housekeeping rules. An audio recording of today's webcast will be available shortly after the call today at Reata's Web site at reatapharma.com in the Investor Section.